NCT02755545

A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments

A Multi-Center Clinical Trial to Evaluate the Efficacy of Two Acne Treatments

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 127 (actual)
• Sponsor: Galderma R&D · Industry
• Sex: All
• Age: 21 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the efficacy of 2 acne treatments for 24 weeks of use in adult men and women with mild to moderate facial acne, at least 5 inflammatory lesions, and at least 10 - 100 non-inflammatory lesions.

Detailed description

1. To characterize the effectiveness of the acne treatment in lesion count at week 1, week 2, week 6, week 12, and week 24 as compared to baseline and compare between treatments 2. To characterize the effectiveness of the acne treatment in Investigator's Global Improvement Assessment at week 1, week 2, week 6, week 12, and week 24 as compared to baseline and compare between treatments 3. To characterize the effect of the acne treatment in clinical grading of efficacy parameters through digital images at week 6, week 12, and week 24 as compared to baseline and compare between treatments 4. To characterize the effect of the acne treatment in subject self-assessment questionnaire responses at week 1, week 2, week 6, week 12, and week 24 as compared to baseline and compare between treatments

Conditions

• Acne

Interventions

Type	Name	Description
DRUG	Product A	Product A applied topically to the entire face or other affected area of the skin once daily
DRUG	Product B	Product B applied topically to affected area of the skin 1 to 3 times daily

Timeline

• Start date: 2016-05-01
• Primary completion: 2017-04-04
• Completion: 2017-04-04
• First posted: 2016-04-29
• Last updated: 2023-12-28
• Results posted: 2023-12-28

Locations

1 site across 1 country: United States